4//SEC Filing
Berkle Sheldon 4
Accession 0001209191-07-006977
CIK 0001340744other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 9:48 AM ET
Size
9.4 KB
Accession
0001209191-07-006977
Insider Transaction Report
Form 4
Berkle Sheldon
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2007-02-01$18.25/sh−9,750$177,938→ 8,000 total - Exercise/Conversion
Common Stock
2007-02-01$3.92/sh+9,750$38,220→ 17,750 total - Exercise/Conversion
Stock Option (Right to buy)
2007-02-01−9,750→ 513,443 totalExercise: $3.92From: 2005-05-09Exp: 2015-05-08→ Common Stock (9,750 underlying)
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Berkle on August 30, 2006.
- [F2]One quarter of these options vested on May 9, 2006, and thereafter an additional 1/48th of the total underlying option grant vests on a monthly basis, such that all options will be vested after four years. In addition, all of these options are immediately exercisable for shares of restricted stock, which are subject to a repurchase right by the Issuer that lapses based on the vesting schedule set forth in the previous sentence.
Documents
Issuer
Altus Pharmaceuticals Inc.
CIK 0001340744
Entity typeother
Related Parties
1- filerCIK 0001350078
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 9:48 AM ET
- Size
- 9.4 KB